BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,466,128,854 | -16.9% | 65,345,227 | +0.3% | 0.07% | -13.4% |
| Q2 2023 | $2,969,114,018 | +15.3% | 65,169,315 | +2.7% | 0.08% | +7.9% |
| Q1 2023 | $2,574,090,399 | -0.0% | 63,463,767 | +25.6% | 0.08% | -6.2% |
| Q4 2022 | $2,575,213,200 | +10.2% | 50,524,097 | +16.4% | 0.08% | +2.5% |
| Q3 2022 | $2,337,481,000 | -10.8% | 43,399,216 | +6.4% | 0.08% | -6.0% |
| Q2 2022 | $2,620,094,000 | -15.5% | 40,792,403 | +2.0% | 0.08% | 0.0% |
| Q1 2022 | $3,101,300,000 | -9.9% | 39,996,135 | -0.3% | 0.08% | -4.5% |
| Q4 2021 | $3,443,054,000 | +9.5% | 40,110,136 | +2.6% | 0.09% | 0.0% |
| Q3 2021 | $3,143,391,000 | +3.6% | 39,082,329 | +3.7% | 0.09% | +4.8% |
| Q2 2021 | $3,034,273,000 | -10.5% | 37,692,832 | -6.3% | 0.08% | -16.0% |
| Q1 2021 | $3,391,518,000 | +3.3% | 40,212,472 | -1.8% | 0.10% | -4.8% |
| Q4 2020 | $3,284,632,000 | -8.4% | 40,935,083 | -8.2% | 0.10% | -20.5% |
| Q3 2020 | $3,586,729,000 | -6.5% | 44,599,949 | +0.1% | 0.13% | -13.7% |
| Q2 2020 | $3,837,405,000 | +14.5% | 44,569,176 | +7.9% | 0.15% | -6.7% |
| Q1 2020 | $3,352,103,000 | -1.7% | 41,287,129 | +1.2% | 0.16% | +25.2% |
| Q4 2019 | $3,411,314,000 | -8.7% | 40,795,426 | -4.5% | 0.13% | -16.6% |
| Q3 2019 | $3,736,353,000 | +12.4% | 42,715,815 | +5.2% | 0.16% | +10.6% |
| Q2 2019 | $3,324,263,000 | +2.1% | 40,589,288 | +1.4% | 0.14% | -2.1% |
| Q1 2019 | $3,254,714,000 | +27.5% | 40,028,474 | +3.2% | 0.14% | +12.4% |
| Q4 2018 | $2,551,757,000 | -16.0% | 38,768,711 | -1.6% | 0.13% | -1.5% |
| Q3 2018 | $3,038,707,000 | -1.5% | 39,417,659 | -5.6% | 0.13% | -7.7% |
| Q2 2018 | $3,083,854,000 | +9.1% | 41,763,993 | -3.9% | 0.14% | +5.2% |
| Q1 2018 | $2,826,630,000 | -7.7% | 43,459,882 | -8.2% | 0.14% | -7.5% |
| Q4 2017 | $3,061,698,000 | -0.2% | 47,365,370 | -3.1% | 0.15% | -5.8% |
| Q3 2017 | $3,068,083,000 | +7.9% | 48,893,756 | +4.1% | 0.16% | +2.6% |
| Q2 2017 | $2,844,598,000 | +16.9% | 46,987,113 | +0.1% | 0.15% | +12.7% |
| Q1 2017 | $2,434,190,000 | +2287.2% | 46,937,709 | +1941.1% | 0.13% | -6.9% |
| Q4 2016 | $101,968,000 | -6.4% | 2,299,657 | +0.5% | 0.14% | -7.7% |
| Q3 2016 | $108,887,000 | +21.9% | 2,287,546 | +15.8% | 0.16% | +16.4% |
| Q2 2016 | $89,353,000 | +55.5% | 1,975,960 | +41.2% | 0.13% | +45.7% |
| Q1 2016 | $57,473,000 | -5.8% | 1,399,084 | -12.5% | 0.09% | +3.4% |
| Q4 2015 | $60,985,000 | +37.1% | 1,598,558 | +18.0% | 0.09% | +27.1% |
| Q3 2015 | $44,489,000 | -70.3% | 1,354,301 | -36.7% | 0.07% | -68.5% |
| Q2 2015 | $149,602,000 | +47.4% | 2,139,299 | +44.4% | 0.22% | +58.6% |
| Q1 2015 | $101,510,000 | -17.4% | 1,481,892 | -11.6% | 0.14% | -20.5% |
| Q4 2014 | $122,851,000 | -21.5% | 1,676,230 | -23.1% | 0.18% | -23.1% |
| Q3 2014 | $156,467,000 | -7.7% | 2,180,111 | -7.1% | 0.23% | -9.1% |
| Q2 2014 | $169,585,000 | +1.6% | 2,345,559 | +3.4% | 0.25% | -6.7% |
| Q1 2014 | $166,943,000 | +5.2% | 2,268,863 | -0.6% | 0.27% | +4.2% |
| Q4 2013 | $158,734,000 | +28.5% | 2,282,284 | +21.4% | 0.26% | +11.2% |
| Q3 2013 | $123,489,000 | -9.0% | 1,879,875 | -4.1% | 0.23% | -13.4% |
| Q2 2013 | $135,757,000 | – | 1,959,822 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |